LEES PHARMACEUTICAL HLDGS financial statements, including revenue, expenses, profit, and loss
The total revenue of 950 for the last semiannual is 540.73 M HKD, and it's 5.55% higher compared to the previous semiannual. The net income of H2 23 is 581.00 k HKD.